Bioengineering,
Journal Year:
2024,
Volume and Issue:
11(12), P. 1220 - 1220
Published: Dec. 3, 2024
Heart
failure
is
characterized
by
intricate
myocardial
remodeling
that
impairs
the
heart’s
pumping
and/or
relaxation
capacity,
ultimately
reducing
cardiac
output.
It
represents
a
major
public
health
burden,
given
its
high
prevalence
and
associated
morbidity
mortality
rates,
which
continue
to
challenge
healthcare
systems
worldwide.
Despite
advancements
in
medical
science,
there
are
no
treatments
address
disease
at
core.
The
development
of
three-dimensional
engineered
vitro
models
closely
mimic
(patho)physiology
drug
responses
myocardium
has
potential
revolutionize
our
insights
uncover
new
therapeutic
avenues.
Key
aspects
these
include
precise
replication
extracellular
matrix
structure,
cell
composition,
micro-architecture,
mechanical
electrical
properties,
relevant
physiological
pathological
stimuli,
such
as
fluid
flow,
load,
signal
propagation,
biochemical
cues.
Additionally,
fully
capture
heart
diversity
vivo,
it
crucial
consider
factors
age,
gender,
interactions
with
other
organ
external
influences—thereby
recapitulating
unique
patient
phenotypes.
This
review
details
model
features
their
significance
research,
aim
enhancing
future
platforms
will
deepen
understanding
facilitate
novel,
effective
therapies.
Cells,
Journal Year:
2024,
Volume and Issue:
13(3), P. 250 - 250
Published: Jan. 29, 2024
The
human
heart
lacks
significant
regenerative
capacity;
thus,
the
solution
to
failure
(HF)
remains
organ
donation,
requiring
surgery
and
immunosuppression.
demand
for
constructed
cardiac
tissues
(CCTs)
model
treat
disease
continues
grow.
Recent
advances
in
induced
pluripotent
stem
cell
(iPSC)
manipulation,
CRISPR
gene
editing,
3D
tissue
culture
have
enabled
a
boom
iPSC-derived
CCTs
(iPSC-CCTs)
with
diverse
types
architecture.
Compared
2D-cultured
cells,
iPSC-CCTs
better
recapitulate
biology,
demonstrating
potential
advance
modeling,
drug
discovery,
medicine,
though
could
benefit
from
methods
faithfully
mimic
physiology
electrophysiology.
Here,
we
summarize
future
developments
vascularization,
immunization,
maturation
of
study
therapy.
The Journal of Physiology,
Journal Year:
2024,
Volume and Issue:
602(16), P. 3871 - 3892
Published: July 20, 2024
Abstract
A
transformation
is
underway
in
precision
and
patient‐specific
medicine.
Rapid
progress
has
been
enabled
by
multiple
new
technologies
including
induced
pluripotent
stem
cell‐derived
cardiac
myocytes
(iPSC‐CMs).
Here,
we
delve
into
these
advancements
their
future
promise,
focusing
on
the
efficiency
of
reprogramming
techniques,
fidelity
differentiation
lineage,
functional
characterization
resulting
myocytes,
many
applications
silico
models
to
understand
general
mechanisms
controlling
excitation–contraction
coupling
health
disease.
Furthermore,
explore
current
potential
iPSC‐CMs
both
research
clinical
settings,
underscoring
far‐reaching
implications
this
rapidly
evolving
field.
image
Frontiers in Physiology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 12, 2024
Ion
channels
and
cytoskeletal
proteins
in
the
cardiac
dyad
play
a
critical
role
maintaining
excitation-contraction
(E-C)
coupling
provide
homeostasis.
Functional
changes
these
proteins,
whether
induced
by
genetic,
epigenetic,
metabolic,
therapeutic,
or
environmental
factors,
can
disrupt
normal
electrophysiology,
leading
to
abnormal
E-C
arrhythmias.
Animal
models
heterologous
cell
cultures
platforms
elucidate
pathogenesis
of
arrhythmias
for
basic
research;
however,
traditional
systems
do
not
truly
reflect
human
electro-pathophysiology.
Notably,
patients
with
same
genetic
variants
inherited
channelopathies
(ICC)
often
exhibit
incomplete
penetrance
variable
expressivity
which
underscores
need
establish
patient-specific
disease
comprehend
mechanistic
pathways
determine
personalized
therapies.
Patient-specific
pluripotent
stem
cell-derived
cardiomyocytes
(iPSC-CMs)
inherit
background
patient
electrophysiological
characteristics
native
cardiomyocytes.
Thus,
iPSC-CMs
an
innovative
translational
pivotal
platform
modeling
therapeutic
screening.
In
this
review,
we
will
examine
how
historically
evolved
model
arrhythmia
syndromes
dish,
their
utility
understanding
specific
ion
functional
causing
We
also
CRISPR/Cas9
have
enabled
establishment
patient-independent
variant-induced
iPSC-CMs-based
models.
Next,
limitations
using
respect
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: March 28, 2025
The
intimate
correlation
between
cardiovascular
diseases
and
other
organ
pathologies,
such
as
metabolic
kidney
diseases,
underscores
the
intricate
interactions
among
these
organs.
Understanding
inter-organ
communications
is
crucial
for
developing
more
precise
drugs
effective
treatments
systemic
diseases.
While
animal
models
have
traditionally
been
pivotal
in
studying
interactions,
human-induced
pluripotent
stem
cells
(hiPSCs)
offer
distinct
advantages
when
constructing
vitro
models.
Beyond
conventional
two-dimensional
co-culture
model,
hiPSC-derived
humanoid
organoids
emerged
a
substantial
advancement,
capable
of
replicating
essential
structural
functional
attributes
internal
organs
vitro.
This
breakthrough
has
spurred
development
multilineage
organoids,
assembloids,
organoids-on-a-chip
technologies,
which
allow
enhanced
physiological
relevance.
These
technologies
shown
great
potential
mimicking
coordinated
organogenesis,
exploring
disease
pathogenesis,
facilitating
drug
discovery.
As
central
system,
heart
serves
focal
point
an
extensively
studied
network
interactions.
review
focuses
on
advancements
challenges
organs,
presenting
comprehensive
exploration
this
cutting-edge
approach
research.
Journal of Molecular and Cellular Cardiology Plus,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100295 - 100295
Published: March 1, 2025
Human
induced
Pluripotent
Stem
Cell-derived
cardiomyocytes
(hiPSC-CMs)
are
increasingly
used
to
identify
potential
factors
capable
of
inducing
endogenous
cardiomyocyte
proliferation
regenerate
the
injured
heart.
L-type
calcium
channel
blockers
have
previously
been
identified
as
a
class
matured
hiPSC-CMs
proliferate.
However,
mechanism
by
which
promote
hiPSC-CM
remains
unclear.
Here
we
provide
evidence
that
possess
plasticity
undergo
dematuration
in
response
certain
pharmacological
compounds.
Consistent
with
primary
maturation
during
perinatal
development,
found
centrosome
disassembly
occurs
plate-based,
temporal,
maturation.
A
small
molecule
screen
nitrendipine,
an
blocker,
and
1-NA-PP1,
Src
kinase
inhibitor,
reassembly
subpopulation
hiPSC-CMs.
Furthermore,
centrosome-positive
were
more
likely
exhibit
cell
cycle
activity
than
centrosome-negative
In
contrast,
neither
nitrendipine
or
1-NA-PP1
reassembly,
activity,
neonatal
rat
ventricular
myocytes
(NRVMs).
Differential
bulk
transcriptome
analysis
indicated
hiPSC-CMs,
but
not
NRVMs,
treated
dematuration.
ScRNA
supported
either
Collectively,
our
results
indicate
compounds
such
Src-kinase
inhibitors.
This
study
shows
once
mature,
may
maintain
their
maturity
under
experimental
conditions
implications
for
systems
where
state
is
relevant.
ACS Applied Bio Materials,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 9, 2025
Heart
failure
(HF)
is
a
major
contributor
to
the
global
burden
of
cardiovascular
disease.
Current
treatments
for
HF
do
not
regenerate
or
restore
cardiac
muscle
function,
leaving
transplantation
as
only
definitive
treatment
end-stage
HF.
Subsequently,
there
tremendous
need
alternative
well
methods
effectively
and
selectively
deliver
those
therapies
heart.
We
have
engineered
an
injectable
reverse
thermal
gel
(RTG)
functionalized
with
carbon
nanotubes
(CNTs)
create
thermoresponsive
conductive
hydrogel
RTG-CNT.
The
RTG-CNT
transitions
from
liquid
solution
gel-based
matrix
upon
reaching
body
temperature,
unique
quality
that
allows
rapid
injection
polymeric
followed
by
localization
in
situ.
Previously,
we
demonstrated
potential
use
tissue
engineering
applications
using
three-dimensional
(3D)
cocultures
primary
cells.
Here,
performed
preclinical
study
assess
biocompatibility
our
vivo
intracardial
mouse
model
vitro
3D
cultures
human-induced
pluripotent
stem
cell-derived
cardiomyocytes.
In
this
report,
present
compelling
results
demonstrate
its
applications.
Egyptian Liver Journal,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Nov. 12, 2024
Abstract
Background
Polyploidization,
a
process
where
cells
acquire
additional
chromosome
sets,
is
unique
characteristic
of
hepatocytes.
This
has
been
increasingly
recognized
as
an
adaptive
mechanism
for
maintaining
liver
function
during
aging,
period
characterized
by
cellular
senescence,
DNA
damage,
and
metabolic
dysregulation.
Purpose
review
explores
the
molecular
mechanisms
underlying
hepatocyte
polyploidization
its
potential
role
in
promoting
resilience
against
aging-related
decline
function.
We
assess
how
polyploid
hepatocytes
contribute
to
genomic
stability,
stress
resistance,
adaptation,
highlighting
their
relevance
aging.
Main
body
Hepatocyte
occurs
through
such
cytokinesis
failure
endoreplication,
leading
binuclear
or
mononuclear
cells.
Polyploid
exhibit
enhanced
repair
capacity,
which
helps
mitigate
accumulation
age-related
damage.
The
increased
gene
dosage
facilitates
better
responses,
particularly
oxidative
genotoxic
insults.
Metabolic
adaptations,
including
xenobiotic
metabolism
lipid
regulation,
further
support
liver’s
ability
maintain
homeostasis
Additionally,
demonstrate
altered
epigenetic
landscapes
proteostasis
mechanisms,
contributing
improved
reduced
susceptibility
senescence.
These
adaptations
collectively
enhance
structural
challenges.
Conclusion
represents
critical
protective
that
safeguard
instability,
dysfunction,
stress.
Understanding
pathways
driving
could
pave
way
novel
therapeutic
strategies
combat
disorders
health
span.
Graphical
Medical Review,
Journal Year:
2024,
Volume and Issue:
4(1), P. 68 - 85
Published: Feb. 1, 2024
Cardiovascular
research
has
heavily
relied
on
studies
using
patient
samples
and
animal
models.
However,
often
miss
the
data
from
crucial
early
stage
of
cardiovascular
diseases,
as
obtaining
primary
tissues
at
this
is
impracticable.
Transgenic
models
can
offer
some
insights
into
disease
mechanisms,
although
they
usually
do
not
fully
recapitulate
phenotype
diseases
their
progression.
In
recent
years,
a
promising
breakthrough
emerged
in
form
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(14), P. 7971 - 7971
Published: July 21, 2024
Human
pluripotent
stem
cell-derived
cardiomyocytes
(hPSC-CMs)
have
emerged
as
a
promising
tool
for
studying
cardiac
physiology
and
drug
responses.
However,
their
use
is
largely
limited
by
an
immature
phenotype
lack
of
high-throughput
analytical
methodology.
In
this
study,
we
developed
testing
platform
utilizing
hPSC-CMs
to
assess
the
cardiotoxicity
effectiveness
drugs.
Following
optimized
differentiation
maturation
protocol,
exhibited
mature
CM
morphology,
phenotype,
functionality,
making
them
suitable
applications.
We
monitored
intracellular
calcium
dynamics
using
imaging
techniques
measure
spontaneous
oscillations
in
presence
or
absence
test
compounds.
For
test,
were
treated
with
various
compounds,
flux
was
measured
evaluate
effects
on
dynamics.
found
that
cardiotoxic
drugs
withdrawn
due
adverse
reactions,
including
encainide,
mibefradil,
cetirizine,
toxicity
but
not
HEK293-hERG
cells.
Additionally,
exposed
ATX-II,
sodium
current
inducer
mimicking
long
QT
syndrome
type
3,
followed
exposure
The
observed
changes
following
demonstrated
utility
versatile
model
system
assessing
both
efficacy.
Overall,
our
findings
highlight
potential
advancing
discovery
development,
which
offer
physiologically
relevant
preclinical
screening
novel
therapeutics.
Frontiers in Physiology,
Journal Year:
2023,
Volume and Issue:
14
Published: Dec. 12, 2023
Human-induced
stem
cell-derived
cardiomyocytes
(hiPSC-CMs)
are
a
valuable
tool
for
studying
development,
pharmacology,
and
(inherited)
arrhythmias.
Unfortunately,
hiPSC-CMs
depolarized
spontaneously
active,
even
the
working
cardiomyocyte
subtypes
such
as
atrial-
ventricular-like
hiPSC-CMs,
in
contrast
to
situation
atria
ventricles
of
adult
human
hearts.
Great
efforts
have
been
made,
using
many
different
strategies,
generate
more
mature,
quiescent
with
close-to-physiological
resting
membrane
potentials,
but
despite
promising
results,
it
is
still
difficult
obtain
properties.
The
dynamic
clamp
technique
allows
inject
current
characteristics
inward
rectifier
potassium
(IK1),
computed
real
time
according
actual
potential,
into
patch-clamped
during
action
potential
measurements.
This
results
potential.
As
result,
measurements
can
be
performed
normal
ion
channel
availability,
which
particularly
important
physiological
functioning
cardiac
SCN5A-encoded
fast
sodium
(INa).
We
vitro
silico
experiments
assess
beneficial
effects
dissecting
functional
consequences
SCN5A-1795insD+/-
mutation.
In
two
separate
sets
patch-clamp
on
control
mutations
ACADVL
GNB5,
we
assessed
value
detecting
delayed
afterdepolarizations
investigating
factors
that
modulate
conclude
has
highly
all
aforementioned
settings
should
widely
used
studies
while
waiting
ultimate
fully
mature
hiPSC-CMs.